Related Experiment Video
Updated: Sep 30, 2025

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
mt tRFs, New Players in MELAS Disease
Salvador Meseguer1, Mari-Paz Rubio1
1Molecular and Cellular Immunology Laboratory, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is linked to altered mitochondrial tRNA-derived small RNAs (mt tRFs). These mt tRFs show therapeutic potential and can be detected in patient biofluids.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- MELAS is an OXPHOS disease primarily caused by the m.3243A>G mutation.
- This mutation alters mitochondrial tRNA-derived small RNA (mt tRF) expression patterns.
Purpose of the Study:
- To investigate the biological relevance and detectability of specific mt tRFs in MELAS.
- To explore the therapeutic potential of mt tRF mimics.
- To examine the role of Dicer and Ago2 in mt tRF biogenesis.
Main Methods:
- Utilized cybrid models and patient fibroblasts.
- Administered mt 5'-tRF LeuUUR mimic oligonucleotides.
- Detected mt tRFs in urine and blood samples.
- Investigated Dicer and Ago2 localization and activity via immunoprecipitation.
Main Results:
- mt 5'-tRF LeuUUR-m.3243A>G and mt 5'-tRF LeuUUR expression levels are altered in MELAS.
- mt 5'-tRF LeuUUR mimic partially restored mitochondrial respiration.
- mt tRFs are detectable in patient biofluids (urine, blood).
- Dicer and Ago2 localize in mitochondria and are implicated in mt tRF biogenesis.
Conclusions:
- Specific mt tRFs are biologically relevant in MELAS.
- mt tRF mimics hold therapeutic promise for MELAS.
- Dicer and Ago2 may play a role in mt tRF biogenesis and function.
More Related Videos
06:50Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
Published on: October 4, 2024
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024